Biovica International Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.
Biovica establishes DiviTum(R) TKa Commercialization Partnership in Italy Read More »
Beactica Therapeutics AB, the Swedish precision oncology company, and Oscotec Inc., the Korean drug development company, announced that they have mutually agreed to terminate their collaboration and licensing agreement.
Beactica Therapeutics and Oscotec mutually agree to conclude oncology collaboration Read More »
RELIEF THERAPEUTICS Holding SA announced it has called an extraordinary general meeting of shareholders to be held at 10:00 a.m. CEST on Friday, April 28, 2023 in Geneva.
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders Read More »
PHC Corporation and NovaScan, Inc. announce the launch of a collaboration through which they will seek to explore the feasibility of MarginScanTM, an investigational “ex vivo” medical device that will seek to support physicians in detecting non-melanoma skin cancers.
Skanska has signed a contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
OKYO Pharma Limited announces that it has applied to the UK Financial Conduct Authority and London Stock Exchange plc to effect a cancellation of its ordinary shares of no par value each from listing on the standard segment of the FCA’s Official List and trading on the main market for listed securities of the LSE
Notice of Intention to Delist From The London Stock Exchange Read More »
Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that three German-based companies have selected ColoAlert®, the Company’s highly efficacious and easy-to-use screening test for colorectal cancer into their respective corporate health programs.
La prevalencia de sentimientos de angustia emocional aumentó del 25 al 31 % entre 2009 y 2021
Amar Desai is back at UnitedHealth as senior adviser to its CEO Andrew Witty.
UnitedHealth executive returns to company 6 months after leaving for CVS Read More »
The San Diego-based DNA-sequencing company, which also faces a challenge from European antitrust regulators, said it will appeal the FTC’s order.
Illumina ordered to divest Grail by FTC on anticompetition concerns Read More »
